Barely Significant
← all excerpts

What Is New in the Treatment of Smoldering Multiple Myeloma?

J Clin Med · 2021 · PMC7865294 · PMID 33499196

Europe PMCDOI
2
hedged sentences
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

a trend towards significancep = 0.07so close (0.05 < p ≤ 0.1)
2% in the control group), although the cumulative risk showed only a trend towards significance ( p = 0.07).

also in 2,760 other papers

indeterminate significanceno p-value reported
Introduction In the continuous spectrum of monoclonal gammopathies, smoldering multiple myeloma (SMM) occupies an intermediate position between what is usually referred to as a pre-malignant condition, i.e., monoclonal gammopathy of indeterminate significance (MGUS) and active multiple myeloma.

also in 137 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.